-
Uncategorized3 weeks agoSTAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and...
-
Uncategorized3 weeks ago
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
Roche, through its subsidiary Genentech, will gain access to the investigational asset HM17321, which is designed to not only elicit weight loss but also improve lean...
-
Uncategorized3 weeks agoFDA plans to regulate generative AI
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Here’s a story you don’t want...
-
Uncategorized3 weeks ago
Kennedy questions vaccination guidelines following Trump’s order to break up MMR
The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or their parents, according to Health Secretary Robert F....
-
Uncategorized3 weeks ago
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
-
Uncategorized3 weeks ago
Qiagen appoints new chief executive after 9-month search
Molecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt takes the reins.
-
Uncategorized3 weeks ago
Pharma marketers need a share-of-answer strategy before AI spend
AI is changing how HCPs seek answers. Pharma marketers need a new strategy. Read More
-
Uncategorized3 weeks agoOpinion: Medicine stopped shaking hands. We should start again
During a recent shift in the emergency department, I helped care for a woman facing a suspected oncologic emergency. She had come to the hospital expecting...
-
Uncategorized3 weeks ago
Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone
Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone
-
Uncategorized3 weeks ago
Adaptive model-guided protein evolution with sparse data optimizes compact eukaryotic genome editors
Nature Biotechnology, Published online: 24 August 2026; doi:10.1038/s41587-026-03272-4 Computational protein evolution with sparse data generates efficient small RNA-guided nucleases.
FDA clears first generic radioligand drug; Sionna turns to layoffs
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
Ensuring safety and accountability in China’s biomedical translation system
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
